Fuji Pharma Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Takayuki Iwai
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 5.8yrs |
Eigendom CEO | 0.04% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | 4.9yrs |
Recente managementupdates
Recent updates
Lacklustre Performance Is Driving Fuji Pharma Co., Ltd.'s (TSE:4554) 27% Price Drop
Aug 05Fuji Pharma's (TSE:4554) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 22Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50
Jul 03Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50
Jun 19Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
May 21Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50
May 13Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00
Feb 28CEO
Takayuki Iwai (60 yo)
5.8yrs
Tenure
Mr. Takayuki Iwai is President & CEO of Fuji Pharma Co., Ltd. from November 2019. He joined the Fuji Pharma Co., Ltd.in October 2019. He was President of Fuji Pharma Co., Ltd. from 2019 to November 2019.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
VP, Executive Officer & Director | no data | geen gegevens | 0.079% ¥ 24.9m | |
Chairman | 33.9yrs | geen gegevens | 34.38% ¥ 10.8b | |
Outside Audit & Supervisory Board Member | 20.9yrs | geen gegevens | 0.030% ¥ 9.6m | |
Vice President & Director | 1.9yrs | geen gegevens | 0.00019% ¥ 59.7k | |
Independent Outside Director | 7.9yrs | geen gegevens | 0.021% ¥ 6.7m | |
Director | less than a year | geen gegevens | 0.0059% ¥ 1.8m | |
Independent Outside Director | 6.9yrs | geen gegevens | 0.021% ¥ 6.7m | |
Outside Audit & Supervisory Board Member | 4.9yrs | geen gegevens | 0.0045% ¥ 1.4m | |
Independent Outside Director | 3.9yrs | geen gegevens | 0.0021% ¥ 647.1k | |
Independent Outside Director | 3.9yrs | geen gegevens | 0.00082% ¥ 257.6k | |
Audit & Supervisory Board Chairman | no data | geen gegevens | 0.033% ¥ 10.3m |
4.9yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 4554 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.9 jaar).